杨茂辉,冉恒泉,王何斌,刘德钦,李劲
YANG Maohui,RAN Hengquan,WANG Hebin,LIU Deqin,LI Jin

• 1:攀枝花学院附属医院肝胆科
• 2:攀枝花市中心医院肝胆外科

摘要(Abstract)：

目的 分析薯蓣皂苷对肝癌Bel-7402细胞增殖和凋亡的影响并探讨其机制。方法 肝癌Bel-7402细胞分为空白组和薯蓣皂苷低、中、高剂量组(给予1、2、8μmol/L的薯蓣皂苷)及薯蓣皂苷+抑制剂组(给予8μmol/L的薯蓣皂苷+10μmol/L的磷脂酰肌醇3激酶/蛋白激酶B(PI3K/AKT)信号通路抑制剂LY294002),于处理后12、24、36、48及72 h时采用四甲基偶氮唑盐(MTT)比色法测定细胞活力，于24 h时采用流式细胞术检测细胞凋亡情况、采用蛋白免疫印迹法(Western blot)检测p-PI3K和p-AKT的表达。结果 与空白组相比较，薯蓣皂苷低、中、高剂量组细胞活力及p-PI3K、p-AKT表达均下降，凋亡率升高(P<0.05),且各剂量组间两两比较，上述指标水平差异均有统计学意义(P<0.05);与薯蓣皂苷高剂量组比较，薯蓣皂苷+抑制剂组细胞活力及p-PI3K、p-AKT表达下降，凋亡率升高(P<0.05)。结论 薯蓣皂苷可能通过抑制PI3K/AKT通路抑制肝癌Bel-7402细胞增殖，诱导Bel-7402细胞凋亡。
Objective To analyze the effect of dioscin on the proliferation and apoptosis of hepatocarcinoma cell line Bel-7402 and explore its mode of action. Methods Bel-7402 cells were divided into blank group, low-, medium-, and high-dose dioscin groups(given 1, 2, 8 μmol/L dioscin, respectively) and dioscin+inhibitor group(given 8 μmol/L dioscin+10 μmol/L LY294002(phosphatidylinositol 3-kinase/protein kinase B(PI3K/AKT) signaling pathway inhibitor)). Tetramethylazolamide(MTT) colorimetry assay was used to detect cell viability at 12, 24, 36, 48, and 72 hours after treatment, and cellular apoptosis was examined at 24 hours using flow cytometry. Western blot was used to detect the expressions of p-PI3K and p-AKT at 24 hours after treatment. Results When compared with blank group, cell viability and expressions of p-PI3K and p-AKT were significantly decreased, while the apoptosis rates were significantly increased in low-, medium-, and high-dose dioscin groups(P<0.05). Pairwise comparison among each dose group showed statistically significant differences in the levels of the above indicators(P<0.05). When compared with the high-dose dioscin group, cell viability and the expressions of p-PI3K and p-AKT in dioscin+inhibitor group were significantly decreased, while the apoptosis rate was significantly increased(P<0.05). Conclusion Dioscin might inhibit proliferation and induce apoptosis of Bel-7402 cells by inhibiting the PI3K/AKT pathway.

关键词(KeyWords)： 肝癌;薯蓣皂苷;磷脂酰肌醇3-激酶/蛋白激酶B;增殖;凋亡
hepatocarcinoma;dioscin;phosphatidylinositol 3-kinase/protein kinase B;proliferation;apoptosis

Abstract:

Keywords:

基金项目(Foundation): 四川省卫生和计划生育委员会科研课题（18PJ507）

作者(Author): 杨茂辉,冉恒泉,王何斌,刘德钦,李劲
YANG Maohui,RAN Hengquan,WANG Hebin,LIU Deqin,LI Jin

DOI: 10.19367/j.cnki.2096-8388.2024.01.013

参考文献(References)：

• [1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
• [2] 冉建朝，代敏，朱琳，等.中国人群肝癌所致DALYs疾病负担：1990—2016年长期分析及预测[J].中国循证医学杂志，2018,18(5):401-409.
• [3] 安澜，曾红梅，郑荣寿，等.2015年中国肝癌流行情况分析[J].中华肿瘤杂志，2019,41(10):721-727.
• [4] 王淑荣，凌霜，张庆光，等.薯蓣皂苷现代药理学研究进展[J].中国药理学通报，2017,33(2):161-166.
• [5] SUN Y,CAO F L,QU L L,et al.MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1[J].Eur Rev Med Pharmacol Sci,2019,23(4):1459-1467.
• [6] KAHRAMAN D C,KAHRAMAN T,CETIN-ATALAY R.Targeting PI3K/Akt/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment[J].Mol Cancer Ther,2019,18(11):2146-2157.
• [7] 董超，罗春香，杨润祥.PI3K/AKT通路及其抑制剂在肺癌治疗中的研究进展[J].中国临床医生杂志，2017,45(10):13-16.
• [8] 潘理会，张平，李春辉.PI3K/AKT/mTOR信号传导通路在胃癌中的研究进展[J].承德医学院学报，2016,33(4):324-327.
• [9] 高亚贤，王永为，宋鸿儒，等.穿龙薯蓣皂苷元体外对CIA小鼠Treg细胞亚群及转录因子的影响[J].中国免疫学杂志，2019,35(21):2593-2598+2603.
• [10]徐静蕾，胡伊乐，杨佳文，等.一氧化氮供体JS-K通过蛋白磷酸酶2A调控磷脂酰肌醇3激酶/蛋白激酶B信号通路诱导人肝癌HEPG2细胞凋亡[J].中国药理学与毒理学杂志，2021,35(7):507-513.
• [11]CHEN W Q,ZHENG R S,BAADE P D ,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
• [12]梁宏元，卢再鸣.原发性肝癌综合介入治疗现状与困惑[J].临床肝胆病杂志，2016(1):44-48.
• [13]邵艳，管静芝.原发性肝癌治疗进展[J].传染病信息，2016,29(4):248-252.
• [14]陈秀梅，赖敏华，李明珍，等.原发性肝癌介入治疗患者的生活质量及影响因素研究[J].护理学报，2016,23(4):68-72.
• [15]刘华.地奥心血康胶囊联合尼可地尔治疗冠心病心肌缺血的临床研究[J].现代药物与临床，2017,32(9):1635-1638.
• [16]徐永金.地奥心血康胶囊联合单硝酸异山梨酯缓释片治疗不稳定型心绞痛临床疗效分析[J].新中医，2016,48(4):26-28.
• [17]李亚，石凤芹，朱陵群，等.新加良附方抑制人胃癌细胞增殖的分子机制[J].世界中医药，2017,12(9):2134-2138.
• [18]茆文莉，周芷晴，王小兰，等.薯蓣皂苷通过调控PI3K/AKT信号通路抑制人肺腺癌细胞H1299上皮间质转化[J].中药新药与临床药理，2019,30(1):39-46.
• [19]宋正伟，张奇能.薯蓣皂苷下调ABCC1表达对人肝癌细胞HepG2/ADM耐药的影响[J].中国药师，2020,23(1):34-39.
• [20]王华，望庐山，梁凤霞，等.基于PI3K/AKT信号通路探讨标本配穴电针对慢性心肌缺血大鼠的保护作用及机制[J].中华中医药杂志，2016,31(9):3475-3480.
• [21]施银，冯晓兰，谢李芬，等.PI3K/AKT信号通路在肿瘤中的研究进展[J].生命的化学，2018,38(3):421-426.
• [22]张春江，赵丹，陈志刚，等.PI3K/Akt/mTOR信号通路对大鼠肾小球系膜细胞增殖的调控作用探讨[J].内科急危重症杂志，2016,22(4):308-311.

文章评论(Comment)：